Gemini DRC NH01 Genetic Screening and Registry Study to Evaluate Long-term Clinical Outcomes and Disease Progression in Subjects with Non-central GA Who Are Carriers of High-risk Genetic Complement Variants Associated with Dry AMD
Research Grant
Administered By
Ophthalmology
Awarded By
Gemini Therapeutics
Start Date
October 10, 2018
End Date
October 18, 2022
Administered By
Ophthalmology
Awarded By
Gemini Therapeutics
Start Date
October 10, 2018
End Date
October 18, 2022